Product Images Fludeoxyglucose F-18

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Fludeoxyglucose F-18 NDC 78714-001 by Barbara Ann Karmanos Cancer Hospital, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - fludeoxyglucose 01

Chemical Structure - fludeoxyglucose 01

PRINCIPAL DISPLAY PANEL - 30 mL Glass Vial Label - fludeoxyglucose 02

PRINCIPAL DISPLAY PANEL - 30 mL Glass Vial Label - fludeoxyglucose 02

Fludeoxvglucose F 18 Injection is a sterile, non-pyrogenic, radioactive material used for diagnostic purposes. It comes in a multiple-dose vial containing 0.74-11.1 GBq (20-300 mCilmL) of no-carrier added Fludeoxyglucose F 18 (2-deaxy-2-[*F]fluoro-D-glucose) @ EOS*and 4.5 mg of sodium chloride in citrate buffer per mL. It should not be used if it is cloudy or if it contains particulate matter. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The item has a shelf life of 109.8 minutes, and the correct dosage should be calculated from the date and time of calibration. This product is for intravenous use only and is intended for diagnostic purposes. Karuanos Cancer nsings in Detroit, MI, is the vendor of this product.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.